Chuikyo Rep Interview 4 - JMA Rep Says Any Reform Must Ensure Access to Appropriate Healthcare

Kimiyuki Nagashima, Executive Board Member, Japan Medical Association As debates for the FY2024 drug pricing reform get into full swing, this occasional interview series aims to illuminate the views of members of the Central Social Insurance Medical Council (Chuikyo). It...read more